Navigation Links
MMD in Medical News

Insmed Announces FDA Issues Statement Regarding Position on Allowing Patients With ALS Access to IPLEX(TM) Under an IND

...ry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, our common stock could be delisted from the Nasdaq Capital Market and other risks and challeng...

Toxic Strand Of RNA Causes Myotonic Muscular dystrophy

...hopes the research might lead to new therapies for mmd in the next few years. "If we develop a therapy to...icroscope. They also integrated an "on switch" for mmd in the mice, activated by giving them doxycycline,...TG repeats, they developed the hallmarks of type 1 mmd within a few weeks, including an inability to rela...
MMD in Medical Technology

Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs

... by Year-End - Enrollment On Track in mmd Clinical Study - ALS Expanded Access Pro...ehrig's disease. A Phase 2 trial of IPLEX(TM) in mmd is on-going and a substantial portion of the exter...e Muscular Dystrophy Association in late 2007. mmd Phase 2 trial at-a-glance: -- All sites have been...

Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy

...lopment, and maximize the market opportunities for mmd available to us." Orphan status is granted by th... years of market exclusivity upon approval for the mmd indication. In addition, Insmed is eligible for ta...e drug candidate through the regulatory process. mmd affects approximately 37,000 Americans, and nearly...
MMD in Biological News

American Chemical Society's Weekly PressPac -- Nov. 19, 2008

...most common form of muscular dystrophy in adults. mmd affects about 1 in 8,000 people. Their findings a...udy, Benjamin Miller and colleagues point out that mmd differs from typical hereditary diseases. They re...tivity and cause symptoms of the disease. Rather, mmd is caused by wayward or "toxic" strands of RNA. ...

Toxic molecule may cause most common type of muscular dystrophy

...sulin resistance. Many people don't know they have mmd until their teens or twenties. To prove the...hopes the research might lead to new therapies for mmd in the next few years. "If we develop a therapy to...croscope. They also integrated an "on switch" for mmd in the mice, activated by giving them doxycycline,...
MMD in Biological Technology

Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

...tial Initiation of Phase II Trial for IPLEX(TM) in mmd Patients with Severe Insulin Resistance - RIC...s of testosterone. The drug was well tolerated in mmd subjects and demonstrated a safety profile consist...ional Phase II trial focused solely on a subset of mmd patients with severe insulin resistance who, based...

Insmed CEO Resigns Due to Health Concerns

...ry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, we may lack financial resources to complete development of product candidates and other risks...

Insmed Announces First Quarter 2009 Financial Results

...orward on all fronts. We continue to expect preliminary Phase 2 results in mmd before the end of the second quarter. In addition, the ALS EAP is set to e...e business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, we may lack financi...

Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule

...ry may experience negative market trends, our continuing efforts to grow the business and develop IPLEX(TM) may be unsuccessful, the actual market for mmd may not actually match up with our external assessment, our common stock could be delisted from the Nasdaq Capital Market and other risks and challeng...

Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results

...ted an external assessment of the total market for mmd treatments that indicated that the market for mmd could be as high as between $800 million and $1.4 ...tinue moving ahead with our IPLEX(TM) programs for mmd and ALS. In addition, we intend to pursue a compr...

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008

...ivity in the current quarter compared to last year as our phase 2 IPLEX(TM) mmd trial continues to progress. SG&A Expenses were consistent quarter over qua....0 million from the Muscular Dystrophy Association supporting the IPLEX(TM) mmd trial. This was partially offset by the absence of license income from Napo...

Insmed and Premacure Cite Study Results Demonstrating Potential Effectiveness of IPLEX(TM) in Preventing Blindness in Premature Infants

...d States in December 2005 for the treatment of children with growth failure due to severe primary IGF-I deficiency, is currently being investigated in mmd and ALS. About ROP ROP is a disease of the eye that affects prematurely born babies. It is thought to be caused by disorganised growth of retinal ...

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008

...ategic financial options will ensure that we make informed decisions for moving our FOB program forward, and advancing the development of IPLEX(TM) in mmd and ALS." Revenues for the second quarter ended June 30, 2008 were $2.6 million, up from $2.3 million for the corresponding period in 2007. The incr...

Insmed Announces First Quarter 2008 Financial Results

...llan, President and CEO of Insmed. "We are aggressively pursuing a partner for our FOB program and continue to advance the development of IPLEX(TM) in mmd and ALS." Revenues for the first quarter ended March 31, 2008 were $2.3 million, up from $1.7 million for the corresponding period in 2007. The incr...

Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results

... portion of the external costs associated with the mmd trial; -- Granted Orphan Drug designation for IPLEX(TM) for the treatment of mmd by the FDA, providing the Company with, among othe...sivity upon approval of IPLEX(TM) for the mmd indication; and -- Completed an external ass...
Other Tags
(Date:7/12/2014)... 2014 The "North ... Devices Market by Angioplasty Balloon (Plain/Old, ... OCT), IVC Filter (Retrievable), Endovascular Stent ... and studies the major market drivers, ... and Canada. , Browse 108 market ...
(Date:7/12/2014)... The fastest-growing mobile technology is LTE ... of LTE networks continues to grow due to the ... have increased mobile data traffic, which is a major ... Communications Test and Measurement equipment comply with industry standards, ... Test and Measurement Market is estimated to grown from ...
(Date:7/12/2014)... injuries increase in the summer as people gather around fire ... most vulnerable to these seasonal fire hazards: children. "Young ... by putting their hands on the side of cooking grills," ... Loyola University Medical Center in Maywood, Ill., said in a ... play with fire, you get burned, is true -- ...
(Date:7/12/2014)... Using and carrying around a catheter bag can ... Va., decided that there needed to be an inconspicuous ... of our design," he said. , They then created ... an inconspicuous way to use and carry a catheter’s ... comfort and peace of mind. Producible in design variations, ...
(Date:7/12/2014)... Wright & Schulte LLC has filed a ... a subsidiary of Johnson & Johnson, on behalf of an ... receiving a metal-on-metal DePuy Pinnacle hip replacement and had to ... hip implant. The DePuy hip lawsuit was filed July 7, ... (Case No. 3:14-cv-2427) where DePuy Pinnacle Hip lawsuit litigation ...
Breaking Medicine News(10 mins):Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:Burn Injuries More Common in Summer 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Ohio Man Who Required Revision Surgery Purportedly From Defective Hip Implant 5
(Date:7/11/2014)... Using spider toxins to study the proteins that let ... say they have stumbled upon a biological tactic that ... insect plagues in a safe and environmentally responsible way. ... be lethal for one species and harmless for a ... target specific pests without harming beneficial species like bees. ...
(Date:7/10/2014)... In Santa Fe, Albuquerque, and other major cities in ... watered with treated municipal wastewater rather than precious potable ... more than 40% of all golf courses receive treated ... courses. , Additionally, golf courses and homeowners alike ... nutrient in fertilizer is nitrate. A New Mexico State ...
(Date:7/10/2014)... NEW YORK , June 27, 2014 /PRNewswire/ ... against Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: ... action, filed in United States District Court, Middle ... Division, is on behalf of a class consisting ... otherwise acquired Provectus securities between December 17, 2013 ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
Other Contents